Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children

被引:23
作者
Preeyasombat, C
Bacchetti, P
Lazar, AA
Lustig, RH
机构
[1] Univ Calif San Francisco, Div Pediat Endocrinol, Dept Pediat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.jpeds.2004.12.014
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives To assess insulin dynamics to oral glucose tolerance testing in obese children, denoting individual contributions of insulin hypersecretion versus resistance to racial and etiopathogenetic specificity. Study design We performed 3-hour oral glucose tolerance testing in 113 nondiabetic obese children (age 13.6 +/- 3.1 years; 41 male, 78 female; 37 black, 41 white; 35 with central nervous system [CNS] insult). The corrected insulin response (CIRgp; measuring beta-cell secretion) and the composite insulin sensitivity, index (CISI) were computed and log-transformed,and each was modeled in terms of the other. plus race/etiology, age, sex, bode, mass index z score, glucose tolerance, pubertal status, and geographic location. Results A scatterplot of logCIRgp versus l ogCISI showed that racial and etiopathogenetic groups plotted indifferent areas. CISI (controlled for CIRgp and other variables) was only 13% lower in blacks than in whites (P = .32). Conversely, CIRgp (controlled for CISI and other variables) was 49% higher in blacks (P = .028). CNS insult exhibited a 40% higher CIRgp (P = .054) and 11% higher CISI (P = .42) than intact white subjects. Conclusions Insulin hypersecretion and resistance are distinct phenomena in childhood obesity. Insulin hypersecretion appears to be the more relevant insulin abnormality both in obese blacks and in CNS insult.
引用
收藏
页码:474 / 481
页数:8
相关论文
共 75 条
[21]  
JEARENAUD B, 1979, PHYSIOL REV, V59, P719
[22]  
KADISH AH, 1968, CLIN CHEM, V14, P116
[23]   Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure [J].
Kanauchi, M ;
Yamano, S ;
Kanauchi, K ;
Saito, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3444-3446
[24]   Beneficial effects of metformin in normoglycemic morbidly obese adolescents [J].
Kay, JP ;
Alemzadeh, R ;
Langley, G ;
D'Angelo, L ;
Smith, P ;
Holshouser, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (12) :1457-1461
[25]   The glucagon-like peptides [J].
Kieffer, TJ ;
Habener, JL .
ENDOCRINE REVIEWS, 1999, 20 (06) :876-913
[26]  
KNUTSON VP, 1991, J BIOL CHEM, V266, P15656
[27]   RELATIONSHIP BETWEEN INVIVO INSULIN RESISTANCE AND DECREASED INSULIN RECEPTORS IN OBESE MAN [J].
KOLTERMAN, OG ;
REAVEN, GM ;
OLEFSKY, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (03) :487-494
[28]  
KREW MA, 1994, OBSTET GYNECOL, V84, P96
[29]   The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity [J].
Le Stunff, C ;
Fallin, D ;
Schork, NJ ;
Bougnères, P .
NATURE GENETICS, 2000, 26 (04) :444-446
[30]   EARLY CHANGES IN POSTPRANDIAL INSULIN-SECRETION, NOT IN INSULIN SENSITIVITY, CHARACTERIZE JUVENILE OBESITY [J].
LESTUNFF, C ;
BOUGNERES, P .
DIABETES, 1994, 43 (05) :696-702